S1P signaling: new therapies and opportunities
Development of sphingosine-1-phosphate receptor 1 (S1P1) modulators to dampen inflammation and its sequelae is becoming increasingly promising for treating medical conditions characterized by significant immunopathology. As shown by the non-selective S1P receptor modulator FTY720 (fingolimod [Gileny...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Revisão |
| Jazyk: | angličtina |
| Vydáno: |
2014
|
| On-line přístup: | https://doi.org/10.12703/p6-109 https://f1000.com/prime/reports/b/6/109/pdf |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|